Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Practice Management > Printed vision chart accurately measures visual acuity at home
  • Practice Management

Printed vision chart accurately measures visual acuity at home

Ophthalmology 360
A printed vision chart can be used at home to measure visual acuity by ophthalmology outpatients with a number of different conditions, according to a study in JAMA Ophthalmology.  The Home Acuity Test (HAT) has the potential to measure visual acuity who do not have access to digital testing.  The diagnostic study included 50 control participants and 100 adult ophthalmology outpatients who reported subjectively stable vision and were attending routine telemedicine clinics.  The mean (SD) test-retest differe

A printed vision chart can be used at home to measure visual acuity by ophthalmology outpatients with a number of different conditions, according to a study in JAMA Ophthalmology.

The Home Acuity Test (HAT) has the potential to measure visual acuity who do not have access to digital testing.

The diagnostic study included 50 control participants and 100 adult ophthalmology outpatients who reported subjectively stable vision and were attending routine telemedicine clinics.

The mean (SD) test-retest difference in the HAT line score was −0.012 (0.06) logMAR, with limits of agreement (LOA) between −0.13 and 0.10 logMAR for participants in the control group. In these patients, the mean (SD) difference in visual acuity compared with conventional vision charts was −0.14 (0.14) logMAR (range, −0.4 to 0.18 log MAR) (−7 letters), with LOA of −0.41 to 0.12 logMAR (−20 to 6 letters).

The mean (SD) difference in visual acuity was −0.10 (0.17) logMAR (range, −0.5 to 0.3 logMAR) (1 line on a conventional logMAR sight chart) for participants in the ophthalmology outpatients’ group. Worse visual acuity was found using the HAT than in previous in-person tests. LOA were −0.44 to 0.23 logMAR (−22 to 12 letters).

Agreement was good for ophthalmology outpatients and control participants in the visual impairment category.

Reference
Crossland MD, Dekker TM, Hancox J, et al. Evaluation of a home-printable vision screening test for telemedicine. JAMA Ophthalmol. Published online January 07, 2021. doi:10.1001/jamaophthalmol.2020.5972

 

Share

Related Content

  • Podcasts

Should you consider a pathway to clinical vision research?

37 Mins Listen
  • Practice Management

Global comparison shows significant differences in waste generated during eye surgery

  • Practice Management

ZEISS turns 100: the evolution of vision care, ophthalmology, and optical innovation

  • IOLs

Sustainability in ophthalmology: actionable tips

  • Practice Management

New review highlights urgent need to tackle adherence gaps in eye care throughout the patient life cycle

  • Trending Topics

Ophthalmic drugs account for a significant share of US drug shortages

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon